Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Madecassic acid is a naturally occurring pentacyclic triterpenoid compound primarily found in the medicinal plant *Centella asiatica* (gotu kola). It acts as an antioxidant and plant metabolite. Preclinical studies have demonstrated that madecassic acid exhibits anti-inflammatory, anti-diabetic, immunomodulatory, and anticancer activities. Its mechanisms include blocking nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) activation and altering lipid metabolism in animal models. Madecassic acid has also been shown to stimulate collagen production—supporting wound healing—and to modulate immune cell populations and induce apoptosis in cancer models[1][3][5][6]. It is considered experimental with no approved pharmaceutical indications.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on madecassic acid.